{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:05:55Z","timestamp":1792181155999,"version":"4.4.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ferroptosis is a promising new target for ovarian cancer (OVCA) treatment. However, some OVCA cell types resist the induction of ferroptosis by limiting the intracellular accumulation of the labile iron pool (LIP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HEY, COV318 and PEO4 were treated with erastin and assessed for cell viability by using PI flow cytometry assays. Erastin-affected iron metabolism was analysed by using FerroOrange assay, Western Blot (WB) analysis of ferritin heavy chain (FtH), transferrin receptor (CD71), and ferroportin (FPN). Mitochondrial reactive oxygen species (mitROS) and lipid peroxidation were quantified via MitoSOX and BODIPY-C11 flow cytometry assays, respectively. Exosomes (EVs) were collected from cell culture media through ultracentrifugation and then enumerated and analyzed by Nanoparticale Tracking Analysis (NTA) and transmission electron microscopy (TEM). CD63 protein expression in EVs was measured through WB by using CD9 as a loading control. Loss-of-function assays for FtH and CD63 were performed by using siRNA-mediated transient transfection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrate that erastin treatment (8 \u00b5M, 8 h) is accompanied by the release of iron-rich ferritin via EV pathway in COV318 and PEO4 OVCA cells, thus failing to exert cytotoxic effects. Mechanistically, erastin causes the upregulation of CD63, a tetraspanin involved in forming multivesicular bodies (MVBs) and EVs, and the increase of MBVs assessed by transmission electron microscopy. Consistent with these findings, EV isolation followed by nanoparticle tracking analysis revealed a significant increase in EVs\/cell in erastin-treated COV318 and PEO4 cells. Notably, EVs harvested from these cells contained CD63 and FtH, a major iron-storage protein. Inhibition of EV biogenesis with GW4869 prevented FtH release and restored LIP accumulation, lipid peroxidation, and ferroptosis sensitivity in COV318 and PEO4 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, our results indicate that OVCA cells can utilize CD63+ EVs to secrete iron-rich ferritin as a mechanism to evade erastin-induced ferroptosis. These findings suggest that combining erastin with EV inhibitors could offer promising strategy for overcoming ferroptosis resistance in OVCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2025.1532097","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T02:47:33Z","timestamp":1741574853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Expulsion of iron-rich ferritin via CD63-mediated exosome drives ferroptosis resistance in ovarian cancer cells"],"prefix":"10.3389","volume":"13","author":[{"given":"Anna Martina","family":"Battaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Petriaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Elzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Esteves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina","family":"Strano Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"De Vitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Costa-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Biamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/ONC.2017.11","article-title":"Iron addiction: a novel therapeutic target in ovarian cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cells9061505","article-title":"Ferroptosis and cancer: mitochondria meet the \u201ciron maiden\u201d cell death","volume":"9","author":"Battaglia","year":"2020","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1208485","DOI":"10.3389\/fcell.2023.1208485","article-title":"Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma","volume":"11","author":"Battaglia","year":"","journal-title":"Front. Cell Dev. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"868351","DOI":"10.3389\/fonc.2022.868351","article-title":"Iron administration overcomes resistance to erastin-mediated ferroptosis in ovarian cancer cells","volume":"12","author":"Battaglia","year":"2022","journal-title":"Front. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1272667","DOI":"10.3389\/FCELL.2023.1272667","article-title":"Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions","volume":"11","author":"Battaglia","year":"","journal-title":"Front. Cell Dev. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12967-021-02744-2","article-title":"Combined lymphocyte\/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility","volume":"19","author":"Biamonte","year":"2021","journal-title":"J. Transl. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14715\/cmb\/2017.63.11.14","article-title":"Human haematological and epithelial tumor-derived cell lines express distinct patterns of onco-microRNAs","volume":"63","author":"Biamonte","year":"2017","journal-title":"Cell Mol. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/J.DEVCEL.2019.10.007","article-title":"Prominin2 drives ferroptosis resistance by stimulating iron export","volume":"51","author":"Brown","year":"2019","journal-title":"Dev. Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1730144","DOI":"10.1080\/23723556.2020.1730144","article-title":"Ferroptosis resistance mediated by exosomal release of iron","volume":"7","author":"Brown","year":"2020","journal-title":"Mol. Cell Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/S41418-019-0393-7","article-title":"Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism","volume":"27","author":"Chen","year":"","journal-title":"Cell Death Differ."},{"key":"B13","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/FCELL.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"","journal-title":"Front. Cell Dev. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fonc.2020.00698","article-title":"FtH-mediated ROS dysregulation promotes CXCL12\/CXCR4 Axis activation and EMT-like trans-differentiation in erythroleukemia K562 cells","volume":"10","author":"Chirillo","year":"2020","journal-title":"Front. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0151359","DOI":"10.1371\/JOURNAL.PONE.0151359","article-title":"FTH1P3, a novel H-ferritin pseudogene transcriptionally active, is ubiquitously expressed and regulated during cell differentiation","volume":"11","author":"Di Sanzo","year":"2016","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12987","DOI":"10.3390\/ijms232112987","article-title":"Ferritin heavy chain binds peroxiredoxin 6 and inhibits cell proliferation and migration","volume":"23","author":"Di Sanzo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/J.CELL.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/ANNUREV-CANCERBIO-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.3390\/cancers14133258","article-title":"Defining optimal conditions for tumor extracellular vesicle DNA extraction for mutation profiling","volume":"14","author":"Elzanowska","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/S12032-023-02237-W","article-title":"Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy","volume":"41","author":"Fu","year":"2023","journal-title":"Med. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/MC.22474","article-title":"Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate","volume":"56","author":"Greenshields","year":"2017","journal-title":"Mol. Carcinog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/leu.2010.126","article-title":"Frequency and clinical correlates of JAK2 46\/1 (GGCC) haplotype in primary myelofibrosis","volume":"24","author":"Guglielmelli","year":"2010","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"778492","DOI":"10.3389\/fonc.2021.778492","article-title":"The role of iron in cancer progression","volume":"11","author":"Guo","year":"2021","journal-title":"Front. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/J.CCELL.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"122720","DOI":"10.1016\/J.LFS.2024.122720","article-title":"Targeting ferroptosis in ovarian cancer: novel strategies to overcome chemotherapy resistance","volume":"349","author":"Kapper","year":"2024","journal-title":"Life Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-019-2081-4","article-title":"Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells","volume":"10","author":"Kleih","year":"2019","journal-title":"Cell Death and Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/CANCERS12123524","article-title":"Iron dysregulation in human cancer: altered metabolism, biomarkers for diagnosis, prognosis, monitoring and rationale for therapy","volume":"12","author":"Leli\u00e8vre","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"665945","DOI":"10.3389\/FONC.2021.665945","article-title":"Ferroptosis in ovarian cancer: a novel therapeutic strategy","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"112784","DOI":"10.1016\/J.EJMECH.2020.112784","article-title":"Exosomes from different cells: characteristics, modifications, and therapeutic applications","volume":"207","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/S12964-023-01369-W","article-title":"Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"B33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/S41416-019-0660-X","article-title":"Activation of the reverse transsulfuration pathway through NRF2\/CBS confers erastin-induced ferroptosis resistance","volume":"122","author":"Liu","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/FPHAR.2017.00244","article-title":"Low-dose paclitaxel inhibits tumor cell growth by regulating glutaminolysis in colorectal carcinoma cells","volume":"8","author":"Lv","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"322612","DOI":"10.3389\/fcell.2018.00018","article-title":"Exosome-based cell-cell communication in the tumor microenvironment","volume":"6","author":"Maia","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/S12935-021-02366-0","article-title":"Induction and application of ferroptosis in cancer therapy","volume":"22","author":"Nie","year":"2022","journal-title":"Cancer Cell Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"23960","DOI":"10.18632\/ONCOTARGET.25251","article-title":"Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing","volume":"9","author":"Oliveira","year":"2018","journal-title":"Oncotarget"},{"key":"B38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-023-01721-6","article-title":"Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential","volume":"9","author":"Ruan","year":"2023","journal-title":"Cell Death Discov. 2023"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0293475","DOI":"10.1371\/JOURNAL.PONE.0293475","article-title":"SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma","volume":"18","author":"Sacco","year":"2023","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/J.CELL.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"151229","DOI":"10.1016\/J.EJCB.2022.151229","article-title":"Tetraspanins interweave EV secretion, endosomal network dynamics and cellular metabolism","volume":"101","author":"Toribio","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/S12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer 2024"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/S12035-022-02738-1","article-title":"Exosome-derived lncRNA NEAT1 exacerbates sepsis-associated encephalopathy by promoting ferroptosis through regulating miR-9-5p\/TFRC and GOT1 Axis","volume":"59","author":"Wei","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"22519","DOI":"10.1038\/srep22519","article-title":"Cells release subpopulations of exosomes with distinct molecular and biological properties","volume":"6","author":"Willms","year":"2016","journal-title":"Sci. Rep. 2016"},{"key":"B45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41420-024-01938-z","article-title":"The crosstalk between exosomes and ferroptosis: a review","volume":"10","author":"Wu","year":"2024","journal-title":"Cell Death Discov. 2024"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/THNO.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/ANTIOX12091739","article-title":"NRF2, a superstar of ferroptosis","volume":"12","author":"Yan","year":"2023","journal-title":"Antioxidants"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/BLOOD.2021010995","article-title":"CD63 is regulated by iron via the IRE-IRP system and is important for ferritin secretion by extracellular vesicles","volume":"138","author":"Yanatori","year":"2021","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1158\/1541-7786.MCR-19-0691","article-title":"A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer","volume":"18","author":"Yang","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/S10565-021-09684-Z","article-title":"Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222\/TFRC axis","volume":"39","author":"Zhang","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.7150\/IJMS.76480","article-title":"Ferroptosis: a new promising target for ovarian cancer therapy","volume":"19","author":"Zhao","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3389\/FONC.2019.01398","article-title":"Erastin reverses ABCB1-mediated docetaxel resistance in ovarian cancer","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0163078","DOI":"10.1371\/JOURNAL.PONE.0163078","article-title":"Caffeine positively modulates ferritin heavy chain expression in H460 cells: effects on cell proliferation","volume":"11","author":"Zolea","year":"2016","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/S41586-020-2732-8","article-title":"Plasticity of ether lipids promotes ferroptosis susceptibility and evasion","volume":"585","author":"Zou","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1532097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:13:40Z","timestamp":1742357620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1532097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":55,"alternative-id":["10.3389\/fcell.2025.1532097"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1532097","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"article-number":"1532097"}}